noscript

News and Announcements

SUDA Investor Presentation May 2016

  • Published May 03, 2016 4:42PM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

3rd May 2016, ASX Announcement

Overview 

SUDA (ASX: SUD) is a drug delivery company commercialising low-risk pharmaceuticals

Extensive proprietary technology, expertise and knowhow in formulating and manufacturing oral sprays

Multiple patent families covering approx. 300 widely-used drugs formulated into oral sprays

SUDA’s first-in-class oral sprays have demonstrated meaningful advantages vs. standard-of-care tablets in multiple clinical studies

Multiple oral sprays for large markets – insomnia, malaria, migraine, erectile dysfunction, chemo-induced nausea

Technology proven with 3 products on the market: NitroMist (Nitro-Glycerine), ZolpiMist and Meloxicam (Vet)

To view the presentation please click on the button below.

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now